Blockchain Registration Transaction Record

Hydromer Reports 11% Revenue Growth, Returns to Profitability in Q3 2025

Hydromer announces 11% revenue growth and return to profitability in Q3 2025. The medical coating specialist reports $0.91 million revenue and plans OTC market upgrade.

This financial turnaround demonstrates the growing demand for advanced medical device coatings and surface modification technologies. As healthcare continues to prioritize infection control and device performance, companies like Hydromer play a crucial role in developing coatings that prevent blood clots, resist microbial growth, and improve device functionality. The company's return to profitability and planned market relisting could signal improved stability and growth potential in the medical technology sector, potentially benefiting healthcare providers and patients through enhanced medical device safety and performance.